TH-Z816
TH-Z816 is a reversible inhibitor againstKRAS (G12D) mutation with an IC50 value of 14 μM, which can be used in cancer research[1].
Product Specifications
CAS Number
2847881-42-7
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/th-z816.html
Solubility
10 mM in DMSO
Smiles
C[C@H]1N(CCNC1)C2=C3C(CN(C4=CC=CC5=C4C(C)=CC=C5)CC3)=NC(OC[C@H]6N(CCC6)C)=N2
Molecular Formula
C29H38N6O
Molecular Weight
486.65
References & Citations
[1]Zhongwei Mao, et al. KRAS (G12D) can be targeted by potent inhibitors via formation of salt bridge. Cell Discov. 2022 Jan 25;8 (1) :5.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY401500 100 µg
P311 (NREP) (NM_004772) Human Over-expression Lysate
Sign In for Pricing
View Details 
TRC-C356560-750MG 750 mg
3,3'-((5-Cyanopentyl)azanediyl)dipropanenitrile
Sign In for Pricing
View Details 
